In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery
- 1 January 2005
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 288 (2) , 361-368
- https://doi.org/10.1016/j.ijpharm.2004.10.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systemsJournal of Pharmacy and Pharmacology, 2003
- Synthesis and Biological Evaluation of Paclitaxel−C225 Conjugate as a Model for Targeted Drug Delivery1Bioconjugate Chemistry, 2003
- Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel deliveryJournal of Controlled Release, 2003
- Toxic characteristics of methoxy poly(ethylene glycol)/poly(ε-caprolactone) nanospheres; in vitro and in vivo studies in the normal micePublished by Elsevier ,2002
- Serum Proteins as Drug Carriers of Anticancer Agents: A ReviewDrug Delivery, 1998
- Liposomal delivery of α-Interferon to murine bladder tumor cells via transferrin receptor-mediated endocytosisDrug Delivery, 1998
- A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol)Journal of Pharmacy and Pharmacology, 1997
- Lipid nanoparticles for delivering antitumor drugsInternational Journal of Pharmaceutics, 1997
- Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosisAdvanced Drug Delivery Reviews, 1994
- Liposomes as carriers of different new lipophilic antitumour drugs: A preliminary reportJournal of Microencapsulation, 1994